XTNT - Xtant Medical Holdings, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
3.25
+0.08 (+2.38%)
As of 12:18PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close3.17
Open3.16
Bid0.00 x 1100
Ask0.00 x 900
Day's Range3.16 - 3.33
52 Week Range3.00 - 11.50
Volume4,207
Avg. Volume20,667
Market Cap42.722M
Beta (3Y Monthly)-0.56
PE Ratio (TTM)N/A
EPS (TTM)-8.00
Earnings DateNov 6, 2018 - Nov 12, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    Xtant Medical Announces Appointment of Interim CEO

    Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Michael Mainelli to serve as Interim Chief Executive Officer, replacing Carl O’Connell effective October 12, 2018. Mr. Mainelli joined the Board of Directors in February 2018 and will remain a member of the Board of Directors while serving as Interim Chief Executive Officer. The Company intends to commence a process to recruit a permanent Chief Executive Officer that will include both internal and external candidates.

  • GlobeNewswirelast month

    Xtant Medical Announces Amendments to Credit Facility and Issuance of Warrants

    Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development and commercialization of regenerative medicine products and medical devices, today announced it has executed amendments to its credit facility reducing interest payable, among other provisions. Xtant has also issued warrants for the purchase of 1.2 million shares of common stock. The Company has executed the 24th and 25th amendments to its Amended and Restated Credit Agreement with its lenders.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of XTNT earnings conference call or presentation 8-Aug-18 1:00pm GMT

    Q2 2018 Xtant Medical Holdings Inc Earnings Call

  • GlobeNewswire2 months ago

    Xtant Medical Announces Appointment of Chief Financial Officer

    Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development and commercialization of regenerative medicine products and medical devices, today announced the appointment of Kathie Lenzen as chief financial officer, effective August 20, 2018. Ms. Lenzen will report to Carl O’Connell, Xtant’s chief executive officer. “Ms. Lenzen is an accomplished healthcare executive with significant financial expertise and we are pleased that she is joining our executive management team,” said Carl O’Connell.

  • GlobeNewswire2 months ago

    Xtant Medical Announces Second Quarter 2018 Financial Results

    BELGRADE, MT, Aug. 07, 2018-- Xtant Medical Holdings, Inc., a leader in the development of regenerative medicine products and medical devices, today reported financial and operating results for the second ...

  • GlobeNewswire2 months ago

    Xtant Medical to Issue Second Quarter 2018 Results on August 7, 2018

    Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announces that it will release its financial results for the quarter ended June 30, 2018, after the close of the financial markets on Tuesday, August 7, 2018. An accompanying conference call will be conducted by Carl O'Connell, chief executive officer, and Laura Kendall, interim chief financial officer, to review the results. Please refer to the information below for conference call dial-in information and webcast registration.

  • What Investors Should Know About Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Financial Strength
    Simply Wall St.5 months ago

    What Investors Should Know About Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Financial Strength

    Investors are always looking for growth in small-cap stocks like Xtant Medical Holdings Inc (AMEX:XTNT), with a market cap of US$75.06M. However, an important fact which most ignore is: howRead More...

  • ACCESSWIRE5 months ago

    Xtant Medical Receives FDA 510(K) Clearance for InTice(TM)-C Porous Titanium Cervical Interbody System

    BELGRADE, MT / ACCESSWIRE / May 21, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, announces U.S. Food and Drug Administration (FDA) 510(k) clearance for InTice™-C Porous Titanium Cervical Interbody System. InTice-C is designed using OsteoSync Ti, a best-in-class, cost-effective, highly porous titanium scaffold material for improved implant fixation. The material more closely resembles the bioscaffold of cancellous bone, and further combines Xtant Medical's hardware and biologic portfolios.

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of XTNT earnings conference call or presentation 9-May-18 1:00pm GMT

    Q1 2018 Xtant Medical Holdings Inc Earnings Call

  • ACCESSWIRE5 months ago

    Xtant Medical Announces First Quarter 2018 Financial Results

    BELGRADE, MT / ACCESSWIRE / May 8, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial ...

  • ACCESSWIRE6 months ago

    Xtant Medical to Issue First Quarter 2018 Results on May 8th, 2018

    BELGRADE, MT / ACCESSWIRE / May 2, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the quarter ended March 31, 2018, after the close of the financial markets on Tuesday, May 8, 2018. An accompanying conference call will be conducted by Carl O'Connell, Chief Executive Officer and President, and Laura Kendall, Interim Chief Financial Officer, to review the results. Please refer to the information below for conference call dial-in information and webcast registration.

  • ACCESSWIRE6 months ago

    Xtant Medical Holdings, Inc. Announces Record Date for Proposed Rights Offering

    BELGRADE, MT / ACCESSWIRE / April 17, 2018 / Xtant™ Medical Holdings, Inc. (NYSE American: XTNT) announced today that it has set April 27, 2018 as the record date for a proposed rights offering of its ...

  • What Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Share Price Doing?
    Simply Wall St.6 months ago

    What Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Share Price Doing?

    Xtant Medical Holdings Inc (AMEX:XTNT), a medical equipment company based in United States, led the AMEX gainers with a relatively large price hike in the past couple of weeks. Less-covered,Read More...

  • ACCESSWIRE7 months ago

    Xtant Medical Holdings, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / April 3, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT ) will be discussing their earnings results in their Q4 Earnings Call to be held on April 3, 2018, at 9:00 ...

  • ACCESSWIRE7 months ago

    Xtant Announces Fourth Quarter and Year End 2017 Financial Results

    BELGRADE, MT / ACCESSWIRE / April 2, 2018 / Xtant™ Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported its financial ...

  • ACCESSWIRE7 months ago

    Xtant Medical to Issue Fourth Quarter and Full Year 2017 Financial Results Monday, April 2

    BELGRADE, MT / ACCESSWIRE / March 27, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that ...

  • Why Did Xtant Medical Holdings Inc (XTNT) Shares Shoot the Lights Out Today?
    SmarterAnalyst8 months ago

    Why Did Xtant Medical Holdings Inc (XTNT) Shares Shoot the Lights Out Today?

    Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) announced today that it received notice from the New York Stock Exchange (NYSE) on February 15, 2018 that the Company has regained compliance with the NYSE’s continued listing standards. The Company will continue to trade on the NYSE American exchange under the symbol “XTNT”. As previously announced, on January 7, 2018, the Company entered into a Restructuring and Exchange Agreement with ROS Acquisition Offshore LP, OrbiMed Royalty Opportunities II, and all of the other holders of all of Xtant's outstanding 6.00% convertible senior unsecured notes due 2021 on January 11, 2017.

  • Who Really Owns Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
    Simply Wall St.9 months ago

    Who Really Owns Xtant Medical Holdings Inc (NYSEMKT:XTNT)?

    In this analysis, my focus will be on developing a perspective on Xtant Medical Holdings Inc’s (AMEX:XTNT) latest ownership structure, a less discussed, but important factor. Ownership structure has beenRead More...

  • Before You Buy Xtant Medical Holdings Inc’s (NYSEMKT:XTNT), You Should Consider This
    Simply Wall St.9 months ago

    Before You Buy Xtant Medical Holdings Inc’s (NYSEMKT:XTNT), You Should Consider This

    If you are looking to invest in Xtant Medical Holdings Inc’s (AMEX:XTNT), or currently own the stock, then you need to understand its beta in order to understand how itRead More...